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rticle history:
s  u  m  m  a  r  y
We  report  the  use  of a novel  graft  material  in  cardiac  surgery,  acellular  human  dermis  graft,  to  repair  a
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left  ventricular  aneurysm  in a patient  undergoing  surgical  ventricular  restoration.  We also  describe  the
postoperative  magnetic  resonance  imaging  characteristics  of the  dermis  graft.  We  conclude  that  acellular
dermis  graft  has  material  handling  properties  that  allow  it to be used  in left  ventricular  aneurysm  repair.
On  magnetic  resonance  imaging,  there  is  no gadolinium  enhancement  of  the  graft  and  the  graft  is  akinetic.
2  Japanese  College  of Cardiology.  Published  by  Elsevier  Ltd.  All rights  reserved.
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Patients suffering from congestive heart failure secondary to
schemic cardiomyopathy and ventricular aneurysm may  beneﬁt
rom surgical ventricular restoration and aneurysmectomy [1–4].
e chose to use acellular dermis instead of traditional synthetic
rafts to repair the left ventricular aneurysm for several reasons.
irst, acellular dermis matrix, which is donated human skin that
as undergone a multistep proprietary process to remove the epi-
ermis and cells which could cause tissue rejection, has been
xtensively used for general surgery reconstruction procedures [5].
t also provides a matrix for the patient’s own blood vessels and cells
o grow into the graft material, unlike other reconstruction mate-
ials [6–8]. In addition, the biological etiology of this material may
e theoretically more resistant to infection than synthetic materials
lso used to repair ventricular aneurysms. To our knowledge, this
s the ﬁrst reported use of acellular dermis graft in cardiac surgical
epair.
ase report
The  patient is a 39-year-old male who had prior history of
yocardial infarction 2 years previously and was treated with coro-
ary artery stenting of the left anterior descending coronary artery.
e most recently presented with recurrent angina. At catheteriza-
ion, there was severe in-stent restenosis and an ejection fraction of
0%. Thrombus was present in the 4.3 cm diameter apical aneurysm
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at echocardiography. Viability studies demonstrated the distal
anteroseptal and inferoapical segments to be ﬁxed consistent with
scar.
Left ventricular aneurysmectomy and reconstruction of the
wall with acellular dermis were performed followed by coro-
nary artery bypass graft. The surgical technique of left ventricular
aneurysmectomy and graft placement was as follows (Fig. 1): after
initiation of cardiopulmonary bypass, the ventricular aneurysm
was resected along a junction identiﬁed between normal contrac-
tile ventricle and the aneurysmal wall in the decompressed left
ventricle. Endocardial resection and cryoablation of the defect bor-
der was  performed. A 3-0 Prolene pursestring was then utilized
vier Ltd. All rights reserved.
P.S. Lim et al. / Journal of Cardiology Cases 6 (2012) e42–e44 e43
Figure 2. Magnetic resonance imaging study at 3 months after surgery. (a) Steady state free precession pulse sequence in pseudo 4 chamber view shows akinetic graft in
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1  weighted image of the left ventricle in the axial plane shows the low signal graft
he  vertical long axis orientation shows the low signal graft (short arrow) along end
o reduce the defect to approximately 3 cm in diameter. Acellu-
ar dermis graft (AlloDerm, LifeCell Corporation, Branchburg, NJ,
SA) of approximately 0.1 cm thickness was cut to the size of the
emaining ventricular defect. The graft was then sewn to the endo-
ardial border of this defect with 4-0 Prolene in a running stitch
o reconstruct the luminal geometry of the left ventricle to as
ormal as possible. The ventricular myocardium was then approx-
mated along the epicardial side of the acellular dermis graft. The
raft borders were marked with metal clips to more accurately
dentify its location on magnetic resonance imaging (MRI). This
atient was imaged preoperatively and at 3 and 9 months after
urgery.
MRI was performed on a 1.5 Tesla Philips Intera (Release 12;
est, Netherlands) using a 5 channel cardiac coil and the follow-
ng sequences: steady state free precession sequences, T1 and T2
eighted, resting perfusion, and 2- and 3-dimensional delayed
nversion recovery post gadolinium sequences in standard cardiac
hamber views. Multihance (gadobenate diglumine) gadolinium
ontrast dose of (0.1 mmol/kg body weight) was used.
Results at 3 and 9 months after surgery, the patient had a sta-
le postoperative ejection fraction of 40% by MRI  and New York
eart Association (NYHA) Class 1 functional classiﬁcation. At 3
ears after surgery, the patient remains at NYHA Class 1 functional
tatus. The acellular dermis graft has low signal on T1 and T2 inver-
ion recovery sequences and was akinetic during cine wall motion
nalysis (Fig. 2a and b). There was no gadolinium enhancement on
arly and delayed imaging of the graft material (Fig. 2c and d). Anw shows akinetic graft in systole (arrow). (c) Immediate post gadolinium contrast
w). (d) Delayed post gadolinium contrast T1 weighted image of the left ventricle in
ial surface in area of hyperintense infarction (long arrow).
accepted standard for the detection of ventricular thrombus is a
low signal intraventricular mass on delayed contrast enhancement
imaging [9]. From other experience with acellular graft dermis we
note that the graft can be differentiated from ventricular throm-
bus by prior knowledge of the use of the graft material and
by observing that, unlike thrombus, the smooth contour of the
graft is contiguous with the endocardial surface of the adjacent
myocardium.
Discussion
We present our use and MRI  evaluation of acellular dermis graft
in left ventricular aneurysm repair. First, acellular dermis graft has
material handling properties that allow it to be used in left ventric-
ular surgery. Second, although prior general surgical studies have
shown pathologic conﬁrmation that new capillaries form within
graft used in hernia repairs, the graft utilized to repair the left ven-
tricular aneurysm was akinetic and did not enhance with contrast
by MRI. We  cannot demonstrate by MRI  that cells have grown into
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